0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 107.22.120.91. Please contact the publisher to request reinstatement.
ARTICLE |

Estrogens and Risk of Breast Cancer-Reply

Phyllis A. Wingo, MS; Peter M. Layde, MD; Nancy Lee, MD
JAMA. 1987;257(16):2166. doi:10.1001/jama.1987.03390160051018.
Text Size: A A A
Published online

In Reply.—  Drs Lemon and Foley incorrectly cite the data from our report and overstate our conclusions; however, we agree with their recommendation that further research is needed to clarify the risk of breast cancer among women who have used estrogen replacement therapy (ERT). First of all, the total numbers of cases and controls included in our analysis were 1369 and 1645, respectively, not 942 and 1117 as cited by the authors. Second, 56 cases and 81 controls used ERT for at least ten years; 114 cases and 154 controls first used ERT at least ten years ago. Finally, in our report, because of the widespread use of ERT1 and the inconsistencies and limitations of available data (including our report), we urged further study of the effects of long-term and high-dosage use and emphasized the importance of identifying subgroups of women who may be at increased risk of breast

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();